venBio Global Strategic Fund II L.P.

Insider Reports History

Entity
Company
Location
1700 Owens Street, Suite 595, San Francisco, CA
Signature
venBio Global Strategic Fund II, L.P., by: venBio Global Strategic GP II, L.P., its general partner, by: venBio Global Strategic GP II, Ltd., its general partner, by: /s/ David Pezeshki, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by venBio Global Strategic Fund II L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Checkmate Pharmaceuticals, Inc. 10%+ Owner Common Stock 2.16M $22.5M $10.45 May 16, 2022 Direct

Insider Reports Filed by venBio Global Strategic Fund II L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CMPI Checkmate Pharmaceuticals, Inc. May 13, 2022 2 -$1.38M 4 May 17, 2022 10%+ Owner
CMPI Checkmate Pharmaceuticals, Inc. May 10, 2022 3 -$1.67M 4 May 12, 2022 10%+ Owner
CMPI Checkmate Pharmaceuticals, Inc. May 5, 2022 3 -$899K 4 May 9, 2022 10%+ Owner
CMPI Checkmate Pharmaceuticals, Inc. May 2, 2022 3 -$2.81M 4 May 4, 2022 10%+ Owner
CMPI Checkmate Pharmaceuticals, Inc. Apr 27, 2022 3 -$1.97M 4 Apr 29, 2022 10%+ Owner
CMPI Checkmate Pharmaceuticals, Inc. Apr 22, 2022 3 -$1.35M 4 Apr 26, 2022 10%+ Owner
CMPI Checkmate Pharmaceuticals, Inc. Apr 19, 2022 3 -$5.7M 4 Apr 21, 2022 10%+ Owner